Orion and Bayer further expand the global clinical development program for the oral androgen receptor inhibitor (ARi)...
CATHAY CARGO SIGNS GLOBAL AIRLINE PARTNERSHIP WITH TOWER COLD CHAIN
Cathay Cargo has signed a global long-term rental agreement with Tower Cold Chain, giving its customers access to a...
At INTERPHEX NYC, KORSCH to Present Enhanced 4th Generation Tablet Press
South Easton, MA - KORSCH America - the US subsidiary of KORSCH AG, the global leader in tablet press technology...
Citeline Finalist CluePoints Show Advanced AI Capabilities
King of Prussia, PA - March 23rd, 2023: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and...
Connect in Pharma releases report on future trends in pharma production and manufacturing
London, UK, 23 March 2023 / Sciad Newswire / A new report from Connect in Pharma published today highlights a range of...
Connect in Pharma releases report on future trends in pharma production and manufacturing
London, UK, 23 March 2023 / Sciad Newswire / A new report from Connect in Pharma published today highlights a range...
NICE publishes guidance recommending Bayer‪s Kerendia (finerenone) as an option for treating adult patients with chronic kidney disease associated with type 2 diabetes
Reading, 23rd March 2023 - Today, the National Institute for Health and Care Excellence (NICE) has published a new...
Teknomek launches Hygienox 2.0 – Exceptionally hygienic furniture for exceptionally clean environments
22 March 2023 - Hygienic furniture specialist Teknomek has enhanced its Hygienox range for cleanrooms with a two-tier...
Benchling Bolsters Success Offerings for Biotech R&D With New Purpose-Built Solutions, Training, and Expert Services
SAN FRANCISCO, March 21, 2023 ó Benchling, the R&D Cloud powering the biotechnology industry, today announced new...
Vaccitech‪s VTP-200 Ph 1b/2 Study Demonstrates Favorable Tolerability and Immunogenicity Profile at Interim Analysis in Women with Low-Grade Human Papillomavirus (HPV)-related Cervical Lesions
OXFORD, United Kingdom, March 20, 2023 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage...
Aggreko Invests £150m into European Fleet over 2022-23
Following the announcement of its One Europe strategy late last year, global provider of modular power, temperature...
Life Science and Healthcare Industry Executive Adam Deutsch Joins uMotif Board as Company Brings the Next-Generation of eCOA/ePRO to Expanding Global Market
BOSTON, Mass. - March 15, 2023 óuMotif - one of the clinical trial technology marketís fastest growing companies -...
